» Articles » PMID: 18592463

Intracytoplasmic Sperm Injection Outcome Using Ejaculated Sperm and Retrieved Sperm in Azoospermic Men

Overview
Journal Urol J
Specialty Urology
Date 2008 Jul 2
PMID 18592463
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: We aimed to determine pregnancy and miscarriage rates following intracytoplasmic sperm injection (ICSI) cycles using retrieved epididymal and testicular sperm in azoospermic men and ejaculated sperm in oligospermic and normospermic men.

Materials And Methods: This retrospective study was carried out on 517 couples who underwent ICSI. They included 96 couples with azoospermia and 421 with oligospermia or normal sperm count in the male partner. Of the men with azoospermia, 69 underwent percutaneous epididymal aspiration (PESA) and 47 underwent testicular sperm extraction (TESE). In the 421 men with oligospermia or normal sperm count, ejaculated sperm was used for ICSI. The differences in the outcomes of ICSI using PESA or TESE and ejaculated sperm were evaluated. The main outcome measures were pregnancy and miscarriage rates.

Results: No significant differences were seen in pregnancy and miscarriage rates with surgically retrieved and ejaculated sperm. The pregnancy rates (including frozen embryo transfer) were 43.5%, 36.2%, and 41.4% in couples with PESA, TESE, and ejaculated sperm, respectively (P = .93). The miscarriage rates were 16.7%, 23.5%, and 12.1%, respectively (P = .37).

Conclusion: Intracytoplasmic sperm injection in combination with PESA and TESE is an effective method and can successfully be performed to treat men with azoospermia. The outcomes with these procedures are comparable to ICSI using ejaculated sperm.

Citing Articles

Percutaneous sperm retrieval technique: A reliable and effective sperm retrieval procedure for ICSI in patients with obstructive azoospermia.

Furtado T, Zeh A, Furtado M JBRA Assist Reprod. 2024; 29(1):103-109.

PMID: 39723884 PMC: 11867246. DOI: 10.5935/1518-0557.20240092.


IVF outcomes following ICSI cycles using testicular sperm in obstructive (OA) vs. non-obstructive azoospermia (NOA) and the impact of maternal and paternal age: a SART CORS data registry.

Sadek S, Matitashvili T, Sharaf Alddin R, Morshedi B, Ramadan H, Dodani S J Assist Reprod Genet. 2023; 40(3):627-637.

PMID: 36662354 PMC: 10033785. DOI: 10.1007/s10815-023-02726-x.


How do we counsel men with obstructive azoospermia due to CF mutations?-a review of treatment options and outcomes.

Persily J, Vijay V, Najari B Transl Androl Urol. 2021; 10(3):1467-1478.

PMID: 33850781 PMC: 8039579. DOI: 10.21037/tau-19-681.


Novel method of histopathological analysis after testicular sperm extraction in patients with nonobstructive and obstructive azoospermia.

Cito G, Coccia M, Picone R, Nesi G, Cocci A, Dabizzi S Clin Exp Reprod Med. 2018; 45(4):170-176.

PMID: 30538947 PMC: 6277673. DOI: 10.5653/cerm.2018.45.4.170.


Potential of testicular sperm to support embryonic development to the blastocyst stage is comparable to that of ejaculated sperm.

Lee S, Park C, Cheon Y, Lim C J Assist Reprod Genet. 2018; 35(6):1103-1111.

PMID: 29728797 PMC: 6030020. DOI: 10.1007/s10815-018-1191-8.